Focus: Camallergy is a UK-based biotechnology company specializing in allergy immunotherapy, positioned in the metabolic diseases therapeutic area. The company operates from Cambridge with limited publicly available scale information.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Camallergy to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Generic amphetamine-derivative with post-LOE status indicates commodity market exposure with minimal differentiation or margin protection.
Help build intelligence for Camallergy
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Camallergy's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
34 discontinued, 15 duplicate formulations not shown
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo